Back to search
Prevention of Chemotherapy-induced Myelosuppression
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Prevention of Chemotherapy-induced Myelosuppression trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Prevention of Chemotherapy-induced Myelosuppression trials you may qualify forThis is a Phase 1b open-label, single arm, multicenter, study of ALRN-6924 as a chemoprotection agent in patients with TP53-mutated HER2- breast cancer (stages…
This is a Phase 1b, multicenter, 2-part study of ALRN-6924 for the prevention of chemotherapy-induced side effects. Part 1 SCLC is an open-label, multicenter s…
The aim of this study is to observe and evaluate the cost-effectiveness,efficacy and safety of PEG-rhG-CSF in preventing chemotherapy-induced neutropenia(CIN) o…
This study aims to analyze the effects of long-acting granulocyte colony stimulating factor (G-CSF) on the prevention febrile neutropenia (FN) in gynecologic ca…